BCM
MDGL icon

Bayesian Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bayesian Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-491
Closed -$225K – 371
2025
Q3 		$225K Sell
491
-889
-64% -$332K 0.05% 442
2025
Q2 		$418K Buy
+1,380
New +$411K 0.07% 324
2025
Q1 		– Sell
-3,573
Closed -$1.1M – 817
2024
Q4 		$1.1M Buy
3,573
+2,071
+138% +$582K 0.13% 217
2024
Q3 		$319K Sell
1,502
-1,907
-56% -$488K 0.04% 465
2024
Q2 		$955K Buy
+3,409
New +$811K 0.11% 244
2023
Q3 		– Sell
-5,860
Closed -$1.35M – 864
2023
Q2 		$1.35M Buy
+5,860
New +$1.59M 0.15% 190
2023
Q1 		– Sell
-2,350
Closed -$682K – 972
2022
Q4 		$682K Buy
+2,350
New +$230K 0.1% 274

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return